Cancer Channel
Related Channels

CeeNU Side Effects

Because CeeNU is an older medication, the specific side effects and how frequently they occur have not been extensively studied. However, possible reactions may include nausea, vomiting, and loss of appetite. Serious complications may also occur, such as fever, unusual bleeding, or mental confusion, which will require prompt medical attention.

An Introduction to CeeNU Side Effects

As with any chemotherapy medicine, CeeNU® (lomustine) can cause side effects. In fact, most people will experience some type of reaction to this drug, and some side effects can be quite significant. Talk to your healthcare provider about ways to prevent or lessen reactions to this medicine.
(This article covers many, but not all, of the possible side effects with CeeNU. Your healthcare provider can discuss a more complete list with you.)

Common Side Effects With CeeNU

For many medications, the prescribing information carefully explains the exact percentage of side effects that were reported in clinical trials. However, the prescribing information for almost all older medications, including CeeNU, includes only vague information on potential side effects, with no exact information on how frequently the reactions may occur. Therefore, it can be difficult to know exactly how common they may be.
Based on available information, some of the more common CeeNU side effects may include:
Nausea and vomiting from CeeNU may occur 3 to 6 hours after your dose, and usually lasts less than 24 hours. Loss of appetite may last for several days after your dose.
7 Natural Ways to Reduce Your Cancer Pain

CeeNU Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.